Skip to main content

Table 2 Characteristics of the patients in early clinical course (ECC) of UC and CD (within 3 years of diagnosis)

From: Changing phenotype, early clinical course and clinical predictors of inflammatory bowel disease in Sri Lanka: a retrospective, tertiary care-based, multi-centre study

Characteristic UC (n = 94) CD (n = 79) P value
Gender    
Male 49 43 0.76
Female 45 36  
Age at diagnosis in years [median and IQR]* 42.7 (29.3–55.9) 34.2 (22.4 – 51.3) 0.04
Duration of diagnosis in months [median and IQR]* 21 (14–27) 21 (14–28) 0.99
Duration of follow up in months [median and IQR]* 18 (5–31) 9 (2–27) 0.01
Disease behavior [number (%)]    
Admission with severe episode 20 (21.3) 9 (11.4) 0.28
Extensive (E2) or Pancolitis (E3) 26 (27.7)
Stricturing (B2) or penetrating (B3) disease 9 (11.4)
Perianal disease (P)   16 (20.5)
Treatment refractoriness [number (%)]    
Steroid dependent 1 (1.1) 0 0.36
Steroid refractory 0 1 (1.3) 0.27
Frequently relapsing 9 (9.6) 6 (7.6) 0.64
Highest therapy    
Immunomodulators 27 (29.0) 48 (61.5)  < 0.01
Anti-TNF agents 3 (3.2) 6 (7.7) 0.19
Disease complications    
Stricture   3 (3.9)  
Perforation   1 (1.3)  
Bleeding 2 (2.1) 0  
Surgery 2 (2.1) 7 (8.9)  
Malignancy 1 (1.1) 1 (1.3)